Detailed TOC of Global Psychedelic Medicine Market Research Report 2025
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psychedelic Medicine Market Size Growth Rate by Type: 2019 VS 2025 VS 2033
1.2.2 Psilocybin
1.2.3 LSD
1.2.4 MDMA
1.2.5 DMT
1.2.6 Ketamine
1.2.7 Others
1.3 Market by Application
1.3.1 Global Psychedelic Medicine Market Growth by Application: 2019 VS 2025 VS 2033
1.3.2 Depressive Disorders
1.3.3 Post-Traumatic Stress Disorders
1.3.4 Substance Abuse Disorders
1.3.5 Obsessive Compulsive Disorders
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psychedelic Medicine Market Perspective (2019-2033)
2.2 Psychedelic Medicine Growth Trends by Region
2.2.1 Global Psychedelic Medicine Market Size by Region: 2019 VS 2025 VS 2033
2.2.2 Psychedelic Medicine Historic Market Size by Region (2019-2025)
2.2.3 Psychedelic Medicine Forecasted Market Size by Region (2025-2033)
2.3 Psychedelic Medicine Market Dynamics
2.3.1 Psychedelic Medicine Industry Trends
2.3.2 Psychedelic Medicine Market Drivers
2.3.3 Psychedelic Medicine Market Challenges
2.3.4 Psychedelic Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psychedelic Medicine Players by Revenue
3.1.1 Global Top Psychedelic Medicine Players by Revenue (2019-2025)
3.1.2 Global Psychedelic Medicine Revenue Market Share by Players (2019-2025)
3.2 Global Psychedelic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Psychedelic Medicine Revenue
3.4 Global Psychedelic Medicine Market Concentration Ratio
3.4.1 Global Psychedelic Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psychedelic Medicine Revenue in 2025
3.5 Psychedelic Medicine Key Players Head office and Area Served
3.6 Key Players Psychedelic Medicine Product Solution and Service
3.7 Date of Enter into Psychedelic Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psychedelic Medicine Breakdown Data by Type
4.1 Global Psychedelic Medicine Historic Market Size by Type (2019-2025)
4.2 Global Psychedelic Medicine Forecasted Market Size by Type (2025-2033)
5 Psychedelic Medicine Breakdown Data by Application
5.1 Global Psychedelic Medicine Historic Market Size by Application (2019-2025)
5.2 Global Psychedelic Medicine Forecasted Market Size by Application (2025-2033)
6 North America
6.1 North America Psychedelic Medicine Market Size (2019-2033)
6.2 North America Psychedelic Medicine Market Growth Rate by Country: 2019 VS 2025 VS 2033
6.3 North America Psychedelic Medicine Market Size by Country (2019-2025)
6.4 North America Psychedelic Medicine Market Size by Country (2025-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psychedelic Medicine Market Size (2019-2033)
7.2 Europe Psychedelic Medicine Market Growth Rate by Country: 2019 VS 2025 VS 2033
7.3 Europe Psychedelic Medicine Market Size by Country (2019-2025)
7.4 Europe Psychedelic Medicine Market Size by Country (2025-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psychedelic Medicine Market Size (2019-2033)
8.2 Asia-Pacific Psychedelic Medicine Market Growth Rate by Region: 2019 VS 2025 VS 2033
8.3 Asia-Pacific Psychedelic Medicine Market Size by Region (2019-2025)
8.4 Asia-Pacific Psychedelic Medicine Market Size by Region (2025-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psychedelic Medicine Market Size (2019-2033)
9.2 Latin America Psychedelic Medicine Market Growth Rate by Country: 2019 VS 2025 VS 2033
9.3 Latin America Psychedelic Medicine Market Size by Country (2019-2025)
9.4 Latin America Psychedelic Medicine Market Size by Country (2025-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psychedelic Medicine Market Size (2019-2033)
10.2 Middle East & Africa Psychedelic Medicine Market Growth Rate by Country: 2019 VS 2025 VS 2033
10.3 Middle East & Africa Psychedelic Medicine Market Size by Country (2019-2025)
10.4 Middle East & Africa Psychedelic Medicine Market Size by Country (2025-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 COMPASS Pathways PLC
11.1.1 COMPASS Pathways PLC Company Detail
11.1.2 COMPASS Pathways PLC Business Overview
11.1.3 COMPASS Pathways PLC Psychedelic Medicine Introduction
11.1.4 COMPASS Pathways PLC Revenue in Psychedelic Medicine Business (2019-2025)
11.1.5 COMPASS Pathways PLC Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Psychedelic Medicine Introduction
11.2.4 Pfizer Revenue in Psychedelic Medicine Business (2019-2025)
11.2.5 Pfizer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Psychedelic Medicine Introduction
11.3.4 Eli Lilly Revenue in Psychedelic Medicine Business (2019-2025)
11.3.5 Eli Lilly Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Psychedelic Medicine Introduction
11.4.4 GlaxoSmithKline Revenue in Psychedelic Medicine Business (2019-2025)
11.4.5 GlaxoSmithKline Recent Development
11.5 Cybin Inc
11.5.1 Cybin Inc Company Detail
11.5.2 Cybin Inc Business Overview
11.5.3 Cybin Inc Psychedelic Medicine Introduction
11.5.4 Cybin Inc Revenue in Psychedelic Medicine Business (2019-2025)
11.5.5 Cybin Inc Recent Development
11.6 Field Trip Health
11.6.1 Field Trip Health Company Detail
11.6.2 Field Trip Health Business Overview
11.6.3 Field Trip Health Psychedelic Medicine Introduction
11.6.4 Field Trip Health Revenue in Psychedelic Medicine Business (2019-2025)
11.6.5 Field Trip Health Recent Development
11.7 ATAI Life Sciences
11.7.1 ATAI Life Sciences Company Detail
11.7.2 ATAI Life Sciences Business Overview
11.7.3 ATAI Life Sciences Psychedelic Medicine Introduction
11.7.4 ATAI Life Sciences Revenue in Psychedelic Medicine Business (2019-2025)
11.7.5 ATAI Life Sciences Recent Development
11.8 NUMINUS WELLNESS
11.8.1 NUMINUS WELLNESS Company Detail
11.8.2 NUMINUS WELLNESS Business Overview
11.8.3 NUMINUS WELLNESS Psychedelic Medicine Introduction
11.8.4 NUMINUS WELLNESS Revenue in Psychedelic Medicine Business (2019-2025)
11.8.5 NUMINUS WELLNESS Recent Development
11.9 MindMed
11.9.1 MindMed Company Detail
11.9.2 MindMed Business Overview
11.9.3 MindMed Psychedelic Medicine Introduction
11.9.4 MindMed Revenue in Psychedelic Medicine Business (2019-2025)
11.9.5 MindMed Recent Development
11.10 HAVN Life Sciences
11.10.1 HAVN Life Sciences Company Detail
11.10.2 HAVN Life Sciences Business Overview
11.10.3 HAVN Life Sciences Psychedelic Medicine Introduction
11.10.4 HAVN Life Sciences Revenue in Psychedelic Medicine Business (2019-2025)
11.10.5 HAVN Life Sciences Recent Development
11.11 Seelos Therapeutics
11.11.1 Seelos Therapeutics Company Detail
11.11.2 Seelos Therapeutics Business Overview
11.11.3 Seelos Therapeutics Psychedelic Medicine Introduction
11.11.4 Seelos Therapeutics Revenue in Psychedelic Medicine Business (2019-2025)
11.11.5 Seelos Therapeutics Recent Development
11.12 Jannsen
11.12.1 Jannsen Company Detail
11.12.2 Jannsen Business Overview
11.12.3 Jannsen Psychedelic Medicine Introduction
11.12.4 Jannsen Revenue in Psychedelic Medicine Business (2019-2025)
11.12.5 Jannsen Recent Development
11.13 Acadia Pharmaceuticals
11.13.1 Acadia Pharmaceuticals Company Detail
11.13.2 Acadia Pharmaceuticals Business Overview
11.13.3 Acadia Pharmaceuticals Psychedelic Medicine Introduction
11.13.4 Acadia Pharmaceuticals Revenue in Psychedelic Medicine Business (2019-2025)
11.13.5 Acadia Pharmaceuticals Recent Development
11.14 Intellipharmaceutics
11.14.1 Intellipharmaceutics Company Detail
11.14.2 Intellipharmaceutics Business Overview
11.14.3 Intellipharmaceutics Psychedelic Medicine Introduction
11.14.4 Intellipharmaceutics Revenue in Psychedelic Medicine Business (2019-2025)
11.14.5 Intellipharmaceutics Recent Development
11.15 Revive Therapeutics
11.15.1 Revive Therapeutics Company Detail
11.15.2 Revive Therapeutics Business Overview
11.15.3 Revive Therapeutics Psychedelic Medicine Introduction
11.15.4 Revive Therapeutics Revenue in Psychedelic Medicine Business (2019-2025)
11.15.5 Revive Therapeutics Recent Development
11.16 Mydecine Innovations Group
11.16.1 Mydecine Innovations Group Company Detail
11.16.2 Mydecine Innovations Group Business Overview
11.16.3 Mydecine Innovations Group Psychedelic Medicine Introduction
11.16.4 Mydecine Innovations Group Revenue in Psychedelic Medicine Business (2019-2025)
11.16.5 Mydecine Innovations Group Recent Development
11.17 Red Light Holland
11.17.1 Red Light Holland Company Detail
11.17.2 Red Light Holland Business Overview
11.17.3 Red Light Holland Psychedelic Medicine Introduction
11.17.4 Red Light Holland Revenue in Psychedelic Medicine Business (2019-2025)
11.17.5 Red Light Holland Recent Development
11.18 Braxia Scientific
11.18.1 Braxia Scientific Company Detail
11.18.2 Braxia Scientific Business Overview
11.18.3 Braxia Scientific Psychedelic Medicine Introduction
11.18.4 Braxia Scientific Revenue in Psychedelic Medicine Business (2019-2025)
11.18.5 Braxia Scientific Recent Development
11.19 Mind Cure Health
11.19.1 Mind Cure Health Company Detail
11.19.2 Mind Cure Health Business Overview
11.19.3 Mind Cure Health Psychedelic Medicine Introduction
11.19.4 Mind Cure Health Revenue in Psychedelic Medicine Business (2019-2025)
11.19.5 Mind Cure Health Recent Development
11.20 Entheon Biomedical
11.20.1 Entheon Biomedical Company Detail
11.20.2 Entheon Biomedical Business Overview
11.20.3 Entheon Biomedical Psychedelic Medicine Introduction
11.20.4 Entheon Biomedical Revenue in Psychedelic Medicine Business (2019-2025)
11.20.5 Entheon Biomedical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
